CFCR will ensure that federal regulations are informed by and grounded in science, best business practices, sound public policy

and social justice principles.

Have a voice in how cannabis is regulated at the federal level.

Ensure that federal regulations support underserved communities and those harmed by the enforcement of prior drug laws.

Bridge the information divide between regulators and stakeholders.

Partner with universities, industry and research organizations in advancing our scientific understanding of cannabis.

Board Members

committee chairs

Science and Regulatory

Affairs Committee

Vice President, R&D,
Front Range Biosciences

Sheri L. Orlowitz

Chair

Founding Partner
Artemis Holdings Group LLC

Sarah A. Chase
Executive Director

Ex-Officio

Mark de Souza
Board Member

CEO

Penrose TherapeuTx

Advisory Board

Judge (Ret.) Jeri B. Cohen

Board Director, Evident Change

​

Myrna Gillis

CEO, Aqualitas

Wendy Hulton

Partner, Dickinson Wright

Jack Jacobson

Advisor, Thompson Coburn LLC

Becky Dansky

ED, Safe & Responsible

Banking Alliance

​

Ida Abdalkhani

Founder, Ability to Engage

​

Hunter Land

Translational Research and

Executive Board Member at
Alterola Biotech, Inc.

​

James Lipetzky

Director, Wild Bill

​

Michael Levin

Founder, Health Business Strategies

​

Marcia Moll

Executive Director, FoodChain ID

​

Darrell Rogers

Founder & CEO, Bin Well Group

​

Matthew Schweber

Of Counsel, Feuerstein Kulick

Mark Spatz

Partner,

Cohen & Gresser

​

Steve Winter

President, Brotman|Winter|Fried

​

Heather Mahoney

Creative Director, 

Haute Haus Agency

Samantha Hart

Creative Director, Wild Bill

partner organizations